Literature DB >> 27233997

Vascular endothelial-cadherin downregulation as a feature of endothelial transdifferentiation in monocrotaline-induced pulmonary hypertension.

Ioanna Nikitopoulou1, Stylianos E Orfanos2, Anastasia Kotanidou1, Violetta Maltabe3, Nikolaos Manitsopoulos1, Panagiotis Karras3, Panos Kouklis3, Apostolos Armaganidis4, Nikolaos A Maniatis5.   

Abstract

Increased pulmonary vascular resistance in pulmonary hypertension (PH) is caused by vasoconstriction and obstruction of small pulmonary arteries by proliferating vascular cells. In analogy to cancer, subsets of proliferating cells may be derived from endothelial cells transitioning into a mesenchymal phenotype. To understand phenotypic shifts transpiring within endothelial cells in PH, we injected rats with alkaloid monocrotaline to induce PH and measured lung tissue levels of endothelial-specific protein and critical differentiation marker vascular endothelial (VE)-cadherin. VE-cadherin expression by immonoblotting declined significantly 24 h and 15 days postinjection to rebound to baseline at 30 days. There was a concomitant increase in transcriptional repressors Snail and Slug, along with a reduction in VE-cadherin mRNA. Mesenchymal markers α-smooth muscle actin and vimentin were upregulated by immunohistochemistry and immunoblotting, and α-smooth muscle actin was colocalized with endothelial marker platelet endothelial cell adhesion molecule-1 by confocal microscopy. Apoptosis was limited in this model, especially in the 24-h time point. In addition, monocrotaline resulted in activation of protein kinase B/Akt, endothelial nitric oxide synthase (eNOS), nuclear factor (NF)-κB, and increased lung tissue nitrotyrosine staining. To understand the etiological relationship between nitrosative stress and VE-cadherin suppression, we incubated cultured rat lung endothelial cells with endothelin-1, a vasoconstrictor and pro-proliferative agent in pulmonary arterial hypertension. This resulted in activation of eNOS, NF-κB, and Akt, in addition to induction of Snail, downregulation of VE-cadherin, and synthesis of vimentin. These effects were blocked by eNOS inhibitor N(ω)-nitro-l-arginine methyl ester. We propose that transcriptional repression of VE-cadherin by nitrosative stress is involved in endothelial-mesenchymal transdifferentiation in experimental PH.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  endothelial-to-mesenchymal transition; endothelin-1; monocrotaline; pulmonary arterial hypertension; vascular endothelial-cadherin

Mesh:

Substances:

Year:  2016        PMID: 27233997     DOI: 10.1152/ajplung.00156.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  8 in total

1.  Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.

Authors:  Toshio Suzuki; Erica J Carrier; Megha H Talati; Anandharajan Rathinasabapathy; Xinping Chen; Rintaro Nishimura; Yuji Tada; Koichiro Tatsumi; James West
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-21       Impact factor: 5.464

2.  Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.

Authors:  Haiyang Tang; Aleksandra Babicheva; Kimberly M McDermott; Yali Gu; Ramon J Ayon; Shanshan Song; Ziyi Wang; Akash Gupta; Tong Zhou; Xutong Sun; Swetaleena Dash; Zilu Wang; Angela Balistrieri; Qiuyu Zheng; Arlette G Cordery; Ankit A Desai; Franz Rischard; Zain Khalpey; Jian Wang; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-26       Impact factor: 5.464

3.  Activation of Nrf2 Attenuates Pulmonary Vascular Remodeling via Inhibiting Endothelial-to-Mesenchymal Transition: an Insight from a Plant Polyphenol.

Authors:  Yucai Chen; Tianyi Yuan; Huifang Zhang; Yu Yan; Danshu Wang; Lianhua Fang; Yang Lu; Guanhua Du
Journal:  Int J Biol Sci       Date:  2017-09-03       Impact factor: 6.580

Review 4.  Endothelial-Vascular Smooth Muscle Cells Interactions in Atherosclerosis.

Authors:  Manna Li; Ming Qian; Kathy Kyler; Jian Xu
Journal:  Front Cardiovasc Med       Date:  2018-10-23

5.  miR-190a-5p participates in the regulation of hypoxia-induced pulmonary hypertension by targeting KLF15 and can serve as a biomarker of diagnosis and prognosis in chronic obstructive pulmonary disease complicated with pulmonary hypertension.

Authors:  Jing Jiang; Yimeng Xia; Yi Liang; Meiling Yang; Wen Zeng; Xiaocong Zeng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-20

6.  Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition.

Authors:  Hui Zhang; Yanjun Lin; Yiwen Ma; Junfeng Zhang; Changqian Wang; Huili Zhang
Journal:  Int J Mol Med       Date:  2019-10-01       Impact factor: 4.101

Review 7.  Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.

Authors:  Anastasia Gorelova; Mariah Berman; Imad Al Ghouleh
Journal:  Antioxid Redox Signal       Date:  2021-04-20       Impact factor: 8.401

Review 8.  Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension.

Authors:  France Dierick; Julien Solinc; Juliette Bignard; Florent Soubrier; Sophie Nadaud
Journal:  Cells       Date:  2021-05-28       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.